Liesbet Deprez studied biomedical sciences with specialisation in genetics at the University of Antwerp (Belgium).
Her scientific career started at the Department of Molecular Genetics of the Flemish Institute for Biotechnology where she performed research on the genetic factors causing idiopathic epilepsy and epilepsy associated with migraine. She obtained a PhD in Biomedical Sciences from the University of Antwerp on May 2007.
In 2009, she joined the Institute for Reference Materials and Measurements of the European Commission’s Joint Research Centre (JRC-IRMM) in Geel, Belgium. Her work is mainly focussed on the development of certified reference materials supporting measurement standardisation in the field of clinical genetic analysis. This research has already led to the production and certification of a reference material for the quantification of a genetic biomarker, called BCR-ABL 1, which is specific for chronic myeloid leukaemia. She also has experience in several novel genetic technologies including quantitative digital PCR.